Trial intelligence / Profile preview

COMBINE: Intravenous Versus Combined Oral and Intravenous Antimicrobial Prophylaxis for the Prevention of Surgical Site Infection in Elective Colorectal Surgery

NCT02618720Phase 3Completed

Sponsor
Centre Hospitalier Universitaire de Clermont-Ferrand
Start
May 2016
Primary completion
Nov 2019
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of ornidazole in surgical site infection (SSI), sponsored by Centre Hospitalier Universitaire de Clermont-Ferrand. Started May 2016; status: completed.

02

Drugs

ornidazole
03

Conditions

surgical site infection (SSI)

Beyond the preview

Go deeper on NCT02618720.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02618720.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call